Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

And Novo (like many others) is already working on next-generation GLPs that’ll have new patent protection before Ozempic’s ends.


Even so, competition from other GLP-1 drugs and generic semaglutide should make prices and profits lower.


If the companies combined can meet demand


They seem to be able to offer it at $300 if you pay without insurance. The implication being that they make 50 extra bucks because the insurance company only pays $250 for your $1,000 prescription.




Consider applying for YC's Fall 2026 batch! Applications are open till July 27.

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: